Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2017 | Aims and impacts of the 100,000 Genomes Project

Anna Schuh • 9 Dec 2017
ASH 2017
General

The exciting 100,000 Genomes Project has the potential to transform the way patients are cared for. Speaking from the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA, Anna Schuh, MD, PhD, from the University of Oxford, UK, discusses the main aims of the project, including access to genetic testing, identification of therapy response markers and database creation. Prof. Schuh emphasizes the wide-reaching impacts of the project, transforming the UK genomics industry.

More from Anna Schuh

AI-REAL: improving diagnosis and treatment in EBV-associated Burkitt lymphoma
Anna Schuh • 25 Mar 2024
3:04
Facilitating diagnosis of Burkitt lymphoma in children in Uganda and Tanzania
Anna Schuh • 7 Oct 2023
1:48
The OxPLoreD study: T-cell type abundance and gene expression in early lymphoproliferative disorders
Anna Schuh • 7 Oct 2023
1:52
Genomic stratification of patients with CLL
Anna Schuh • 7 Oct 2023

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals